{"altmetric_id":7137775,"counts":{"readers":{"mendeley":20,"citeulike":0,"connotea":0},"total":{"posts_count":2},"news":{"unique_users_count":1,"unique_users":["bioportfolio"],"posts_count":1},"blogs":{"unique_users_count":1,"unique_users":[57867],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa5e73cf058f610005940","authors":["Moukharskaya J","Verschraegen C"],"doi":"10.1016\/j.hoc.2012.03.002","endpage":"525","first_seen_on":"2016-05-04T07:44:04+00:00","issns":["0889-8588","08898588"],"issue":"3","journal":"Hematology\/oncology clinics of North America","last_mentioned_on":1462236560,"links":["http:\/\/dx.doi.org\/10.1016\/j.hoc.2012.03.002"],"pmid":"22520977","pubdate":"2012-06-14T23:00:00+00:00","publisher_subjects":[{"name":"Cardiovascular Medicine And Haematology","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"507","subjects":["neoplasms","hematology"],"title":"Topoisomerase 1 Inhibitors and Cancer Therapy","type":"article","volume":"26","mendeley_url":"http:\/\/www.mendeley.com\/research\/topoisomerase-1-inhibitors-cancer-therapy"},"altmetric_score":{"score":12,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":12},"context_for_score":{"all":{"total_number_of_other_articles":8022450,"mean":6.7899936799808,"rank":659695,"this_scored_higher_than_pct":91,"this_scored_higher_than":7350715,"rank_type":"exact","sample_size":8022450,"percentile":91},"similar_age_3m":{"total_number_of_other_articles":269268,"mean":11.444906705983,"rank":32991,"this_scored_higher_than_pct":87,"this_scored_higher_than":236025,"rank_type":"exact","sample_size":269268,"percentile":87},"this_journal":{"total_number_of_other_articles":186,"mean":2.4987783783784,"rank":5,"this_scored_higher_than_pct":97,"this_scored_higher_than":181,"rank_type":"exact","sample_size":186,"percentile":97},"similar_age_this_journal_3m":{"total_number_of_other_articles":12,"mean":5.1363636363636,"rank":2,"this_scored_higher_than_pct":83,"this_scored_higher_than":10,"rank_type":"exact","sample_size":12,"percentile":83}}},"demographics":{"users":{"mendeley":{"by_status":{"Researcher":3,"Student  > Doctoral Student":2,"Student  > Ph. D. Student":6,"Student  > Postgraduate":1,"Student  > Master":3,"Student  > Bachelor":4,"Lecturer":1},"by_discipline":{"Engineering":2,"Medicine and Dentistry":6,"Chemistry":3,"Agricultural and Biological Sciences":6,"Biochemistry, Genetics and Molecular Biology":2,"Unspecified":1}}},"geo":{"mendeley":{"EC":1,"BR":1}}},"posts":{"news":[{"title":"Topoisomerase 1 inhibitors and cancer therapy","url":"http:\/\/ct.moreover.com\/?a=26390597122&p=1pl&v=1&x=RlNsrkwG-kmTcsNIjdQuxQ","license":"public","citation_ids":[7137775],"posted_on":"2016-05-03T00:49:20+00:00","summary":"Topoisomerase 1 & II inhibitors and cancer therapy Larry H. Bernstein, MD, FCAP, Curator LPBI Topoisomerase 1 & II Inhibitors and Cancer Therapy Julia Moukharskaya, Claire Verschraegen, Hematology\/Oncology Clinics of North America June 2012; Volume\u2026","author":{"name":"Bioportfolio","url":"http:\/\/www.bioportfolio.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/821\/normal\/Screen_Shot_2015-12-11_at_16.36.54.png?1449851849"}}],"blogs":[{"title":"Topoisomerase 1 inhibitors and cancer therapy","url":"https:\/\/pharmaceuticalintelligence.com\/2016\/05\/02\/topoisomerase-1-ii-inhibitors-and-cancer-therapy\/","license":"public","citation_ids":[7137775,7137775,21638893,3075049,3075049,3118175,6535600,6535600,4028065,4028065,539698,539698,816869,816869,21638929,21638929,6061030,6061030,6061007,6061007,21638940,21638940,7411469,7411469,21638961,21638961,5098143,5098143],"posted_on":"2016-05-02T23:21:00+00:00","summary":"Topoisomerase 1 &amp; II inhibitors and cancer therapy Larry H. Bernstein, MD, FCAP, Curator LPBI &nbsp; Topoisomerase 1 &amp; II Inhibitors and Cancer Therapy Julia Moukharskaya,&nbsp;Claire Verschraegen, Hematology\/Oncology Clinics of North America&nbsp;","author":{"name":"Pharmaceutical Intelligence","url":"http:\/\/pharmaceuticalintelligence.com\/","description":"A blog specializing in Pharmaceutical Intelligence and Analytics"}}]}}